Dual immunotherapy with neoadjuvant chemotherapy shows encouraging activity in ERBB2-negative breast cancerJuly 30, 2026
Tech CoreMap raises $37m in Medtronic-led financing roundBy Healthcare Propulsion StaffJuly 30, 20260 CoreMap’s electrophysiology mapping system is under development to provide clinicians with more personalised patient insights when conducting atrial fibrilation ablation…
General Qureight closes $20 million Series B financingBy Healthcare Propulsion StaffJuly 30, 20260 Qureight, an end-to-end imaging company that provides enterprise-grade imaging and precision endpoints for clinical trials with a focus on lung…
